You just read:

DelMar Presents Data Supporting VAL-083 as Potential Treatment for Pediatric Brain Tumors at SNO Pediatric Neuro-Oncology Conference

News provided by

DelMar Pharmaceuticals, Inc.

May 06, 2019, 05:30 ET